Figure 1.
Consolidation therapy with blinatumomab improves OS in newly diagnosed adult patients with B-lineage acute lymphoblastic leukemia in MRD-negative remission (ECOG-ACRIN E1910 trial). Treatment chart and OS of randomized patients becoming MRD-negative after induction treatment. Blin, blinatumomab. Reproduced from Litzow et al21 with permission.

Consolidation therapy with blinatumomab improves OS in newly diagnosed adult patients with B-lineage acute lymphoblastic leukemia in MRD-negative remission (ECOG-ACRIN E1910 trial). Treatment chart and OS of randomized patients becoming MRD-negative after induction treatment. Blin, blinatumomab. Reproduced from Litzow et al21 with permission.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal